Vital Therapies (NASDAQ:VTL) Reaches New 12-Month High at $15.00
Shares of Vital Therapies (NASDAQ:VTL) hit a new 52-week high on Friday . The stock traded as high as $15.00 and last traded at $13.92, with a volume of 339712 shares changing hands. The stock had previously closed at $14.05.
Separately, ValuEngine upgraded XPO Logistics from a “strong sell” rating to a “sell” rating in a research report on Thursday, April 4th. Six analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $12.00.
The stock’s fifty day moving average is $8.92.
Vital Therapies Company Profile (NASDAQ:VTL)
Vital Therapies, Inc, a biotherapeutic company, focuses on developing cell-based therapies for the treatment of acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc in June 2003. Vital Therapies, Inc was founded in 2003 and is based in San Diego, California.
Further Reading: How is the Producer Price Index calculated?
Receive News & Ratings for Vital Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Therapies and related companies with MarketBeat.com's FREE daily email newsletter.